12 Implementing Xpert MTB/RIF requires quality assessment. A pilot program using dried 13 culture spots (DCS) of inactivated M.tb is described. Of 274 DCS results received, 2.19% 14 generated errors; the remaining yielded 100% correct Mycobacterium tuberculosis 15 detection. Probe A cycle threshold(Ct) variability of three DCS batches ≤3.47Ct. Longer-16 term DCS stability is on-going. 17 Word count: 50 18 19
2 external quality assessment (EQA) programs is lacking (20) . Current international TB 24 EQA focus on microscopy, culture and susceptibility testing laboratories (27) and 25 highlight the difficulties in expansion due to labour-intensive preparatory work and high 26 cost and regulation for shipping drug resistant isolates (12) . 27 Criteria for a verification ("fit for purpose") and EQA program suited to the Xpert 28 MTB/RIF assay characteristics (3, 8) , will require the following: 1) testing material must 29 contain whole M.tb (8); 2) transportation of EQA material needs to be safe; 3) testing 30 procedure needs to be safe and compatible with the Xpert MTB/RIF current testing 31 protocol; 4) non-laboratory skilled health care workers must be able to perform the 32 testing in non-laboratory settings; and 5) the programs will need to be cost effective and 33 sustainable. Such a program using whole inactivated M.tb spotted onto filter paper was 34 at room temperature before placing in sealed plastic bags with a desiccant sachet (Sigma-64 Aldrich). These were couriered (n=16), hand delivered (n=10), or surface mailed (repeat 65 DCS to 4 sites) to sites, where each spot was cut (using a sterile pair of scissors) into a 66 50ml standard laboratory Nunc centrifuge tube (AEC Amersham) and 2.8ml SR buffer 67 (to ensure there was sufficient 2ml to pipette into the Xpert MTB/RIF cartridge after the 68 DCS incubation) was added to the tube. The tubes were vortexed (or hand shaken by 69 on July 8, 2017 by guest http://jcm.asm.org/ Downloaded from swirling vigorously if no vortexer available) and left at room temperature for 15 min with 70 intermittent mixing. One DCS was then tested on each Xpert MTB/RIF module (unit). 71
The Ct mean, standard deviation and coefficient of variation were calculated for Probe A. 72
Three DCS batches were manufactured for 31 GX's {GX Infinity-48(n=1); GX16 (n=9); 73 GX4 (n=21)}. A total of 286 DCS were distributed to the 26 participating sites, and 74 results received for 274 DCS, thereby identifying sites with non-conformances. Six 75 testing errors [5011 (n=5) and 5007 (n=1)] were reported and the remaining 268 DCS 76 generated results with 100% M.tb positivity and RIF sensitivity (see Table 1 ). Probe A 77 was the first probe to reach the amplification Ct with similar standard deviation across 78 three DCS batches ≤3.47Ct. Frequency distributions in Figure 2 The DCS material proved successful for verifying GX instruments and highlighted 86 expected error code frequencies (2.1%) and site non-conformities. 87
Although this is a uniquely designed EQA program that appears so far suitable for the 88 Xpert MTB/RIF verification using different strains from different culture methods, the 89 individual components are not unfamiliar to the field: filter paper has been used for the 90 transportation and molecular testing of M.tb DNA (7, 17) and flow cytometry has been 91 used for the analysis of M. tb (2, 10, 19, 21, (23) (24) (25) (26) . Flow cytometry has the advantage of 92 on July 8, 2017 by guest http://jcm.asm.org/ Downloaded from rapidly and accurately identifying inactivated single whole bacteria, which circumvents 93 conventional, time consuming colony forming unit (CFU) enumeration methodologies. 94
Flow cytometric event enumeration can also be performed below the minimum 95
McFarlane concentrations (1x10 7 CFU/ml) and could more accurately be used in strain 96 mixing to test 'drop out' or 'delayed Ct' (3). Flow cytometry is also available in settings 97 that currently perform CD4 counting on HIV patients for treatment initiation and 98 monitoring, and therefore is a platform and infrastructure already in place(6). 
